Related Experiment Video

Updated: Aug 12, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Morphine-3-glucuronide has a minor effect on morphine antinociception. Pharmacodynamic modeling

M Gardmark1, M O Karlsson, F Jonsson

  • 1Division of Biopharmaceutics and Pharmacokinetics, Department of Pharmacy, Uppsala University, Box 580, S-751 23 Uppsala, Sweden.

Journal of Pharmaceutical Sciences
|July 2, 1998
PubMed

Insights

Morphine-3-glucuronide (M3G) reduces morphine's pain-relieving effects by 15-20% in rats. M3G did not significantly alter morphine's respiratory effects during the study.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Toxicology

Background:

  • Morphine is a potent analgesic, but its efficacy can be modulated by its metabolites.
  • Morphine-3-glucuronide (M3G) is a major morphine metabolite with poorly understood effects on morphine's actions.

Purpose of the Study:

  • To quantify the impact of M3G on morphine's antinociceptive effect (ANE) and respiratory function in rats.
  • To model the pharmacokinetic-pharmacodynamic relationship between M3G, morphine, and antinociception.

Main Methods:

  • Rats were pretreated with saline or M3G, followed by intravenous morphine infusion.
  • Antinociception was assessed using the electrical stimulation vocalization method.
  • Blood gas parameters (pCO2, pO2, pH) were measured to evaluate respiratory effects.
  • Pharmacokinetic-pharmacodynamic modeling (effect compartment and indirect response models) was employed.

Main Results:

  • All groups showed increased ANE with morphine, but maximal effects differed based on M3G pretreatment.
  • Acute tolerance to morphine's ANE was observed, without rebound effects.
  • Models incorporating M3G provided a better fit to the data, indicating M3G's influence.
  • Naturally occurring M3G levels (15 microM) were predicted to reduce morphine ANE by 15-20%.

Conclusions:

  • M3G significantly modulates morphine's antinociceptive effect, reducing its efficacy.
  • M3G does not appear to substantially alter morphine-induced respiratory depression in this rat model.
  • These findings highlight the importance of considering morphine metabolite activity in pain management strategies.

More Related Videos

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

Intracranial Pharmacotherapy and Pain Assays in Rodents02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model01:29

Pharmacodynamic Models: Direct Effect Model and Indirect Response Model

Pharmacodynamic models are essential tools in understanding the relationship between drug concentrations and their effects on biological systems. By characterizing the dynamics of drug action, these models guide dose selection, optimize therapeutic efficacy, and inform the development of new drugs. Two major classes of pharmacodynamic models include direct effect and indirect response models.Direct Effect ModelsDirect effect models describe the immediate relationship between drug concentration...
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A higher...